Editorial Board Member: Dr Andrew Gennery
Watson Reader/Honorary Consultant in Paediatric Immunology & Haematopoeitic Stem Cell Transplantation. Newcastle University and Great North Children’s Hospital, Newcastle upon Tyne, UK.
Disclosures: Dr Gennery has delivered lectures as part of an ‘in- house’ education staff to GSK Staff – Haematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
Editorial Board member: Dr Robbert Bredius
MD PhD, Paediatric Immunologist – Infectious Disease – Stem Cell Transplant Dr. Department of Paediatrics, Immunology section, Hematology and Stem Cell Transplantation, Leiden University Medical Centre, The Netherlands.
Disclosures: Dr Bredius has delivered industry symposia presentations funded by GSK
Editorial Board member: Dr Fabio Candotti
MD PhD, Pediatrics, Pediatric Allergy and Immunology
Associate Professor of Medicine and Head Physician, Division of Immunology and Allergy
Director, Vaccine and Immunotherapy Center, University Hospital of Lausanne, Switzerland
Disclosures: Dr Candotti has no conflicts of interest to declare.
Expert Interviewee: Professor Marina Cavazzana
Head of the Biotherapy Department, Necker Chidren’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Disclosures: Professor Cavazzana stated that she has no relationships to disclose